MiNK Therapeutics, Inc.

INKT

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091707
Filing date: Mar 4, 2026
Earliest execution date: Feb 27, 2026
Reporting Owners: Ryan Barbara (Director)
SEC Filing link

Summary

Type

Sell

Net shares

-500

% of shares

-2.23%

Amount (USD)

$5,425

Insider confidence score

27.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Negative

  • Large discretionary sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-02-27

Code

S

Net shares

-400.0

Price per Share

$10.86

Amount (USD)

$4,343.32

Acquired/Disposed

Disposed

Shares Owned Before

22,406.0

Shares Owned After

22,006.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-100.0

Price per Share

$10.83

Amount (USD)

$1,082.58

Acquired/Disposed

Disposed

Shares Owned Before

22,006.0

Shares Owned After

21,906.0

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.